Literature DB >> 7739727

In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens.

M Otcenásek1, V Buchta.   

Abstract

Fourteen clinical isolates of Zygomycetes were tested for their in vitro susceptibility to nine antifungal agents. Susceptibility assessment was performed using a microtiter broth dilution method. Synthetic broth with YNB and glucose was used for 5-fluorocytosine and BHI broth for all the other antimycotics. Amphotericin B exhibited the strongest activity against all isolates tested. MIC values of other two polyenes--nystatin and pimaricin--ranged within the susceptibility limits, with a little pronounced higher activity of pimaricin. The isolates of the genus Absidia and Syncephalastrum were well sensitive to all antimycotics with the exception of 5-fluorocytosine and naftifine. A very weak or zero growth inhibitory effect against all members of the genera Mucor and Rhizopus was found in azoles, 5-fluorocytosine and naftifine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7739727     DOI: 10.1007/bf01138473

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  6 in total

Review 1.  Amphotericin B. Still the 'gold standard' for antifungal therapy.

Authors:  G A Sarosi
Journal:  Postgrad Med       Date:  1990-07       Impact factor: 3.840

2.  Orbital mucormycosis with survival.

Authors:  M O'Keefe; W M Haining; J D Young; W Guthrie
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

3.  An amphotericin B-resistant case of rhinocerebral mucor mycosis.

Authors:  J Barnert; W Behr; H Reich
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

4.  In vitro studies with R 51,211 (itraconazole).

Authors:  A Espinel-Ingroff; S Shadomy; R J Gebhart
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

Review 5.  Systemic zygomycosis.

Authors:  E W Benbow; R W Stoddart
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

6.  Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.

Authors:  J Van Cutsem; F Van Gerven; J Fransen; P A Janssen
Journal:  Chemotherapy       Date:  1989       Impact factor: 2.544

  6 in total
  14 in total

1.  Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales.

Authors:  Roxana G Vitale; G Sybren de Hoog; Patrick Schwarz; Eric Dannaoui; Shuwen Deng; Marie Machouart; Kerstin Voigt; Wendy W J van de Sande; Somayeh Dolatabadi; Jacques F Meis; Grit Walther
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.

Authors:  Nikolaos G Almyroudis; Deanna A Sutton; Annette W Fothergill; Michael G Rinaldi; Shimon Kusne
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

3.  In Vitro Antifungal Activities against Moulds Isolated from Dermatological Specimens.

Authors:  Tzar Mohd Nizam; Rabiatul Adawiyah Ag Binting; Shafika Mohd Saari; Thivyananthini Vijaya Kumar; Marianayati Muhammad; Hartini Satim; Hamidah Yusoff; Jacinta Santhanam
Journal:  Malays J Med Sci       Date:  2016-05

Review 4.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Intraabdominal zygomycosis caused by Syncephalastrum racemosum infection successfully treated with partial surgical debridement and high-dose amphotericin B lipid complex.

Authors:  Sanmarié Schlebusch; David F M Looke
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 6.  Fungal infections in patients with neutropenia: challenges in prophylaxis and treatment.

Authors:  R Herbrecht; S Neuville; V Letscher-Bru; S Natarajan-Amé; O Lortholary
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

7.  Rhino-orbital-cerebral mucormycosis.

Authors:  Maria N Gamaletsou; Nikolaos V Sipsas; Emmanuel Roilides; Thomas J Walsh
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 8.  Mucormycosis in a Non-Hodgkin Lymphoma Patient Caused by Syncephalastrum racemosum: Case Report and Review of Literature.

Authors:  Georgina Rodríguez-Gutiérrez; Erika M Carrillo-Casas; Roberto Arenas; Jorge O García-Méndez; Sonia Toussaint; Mónica E Moreno-Morales; Adrián A Schcolnik-Cabrera; Juan Xicohtencatl-Cortes; Rigoberto Hernández-Castro
Journal:  Mycopathologia       Date:  2015-03-05       Impact factor: 2.574

9.  Disseminated zygomycosis due to Rhizopus schipperae after heatstroke.

Authors:  G M Anstead; D A Sutton; E H Thompson; I Weitzman; R A Otto; S K Ahuja
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

10.  Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis.

Authors:  Eric Dannaoui; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.